Aliyar Pirouzi1, Mirzakhalil Bahmani1, Mohammad Mehdi Feizabadi2, Rouhi Afkari1. 1. Cellular and Molecular Gerash Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
INTRODUCTION: Torque teno virus (TTV) and SEN virus are circular single-stranded DNA viruses that cause blood-borne infections. The SEN virus (SEN-V) was originally detected in the serum of an injection drug user infected with human immunodeficiency virus (HIV). Recently TTV was discovered as a potential causative agent of non-A-E hepatitis. The aim of this study was to investigate the prevalence of the SEN-V-D/H and TTV in HIV patients and healthy blood donors in Iran. METHODS: One hundred and fifty HIV patients with a mean age of 50.46 ± 18.46 years and 150 healthy blood donors with a mean age of 48.16 ± 13.73 years were included in this study. TTV and SEN-V were detected by the PCR and were quantitatively assayed by competitive PCR (nested and semi-nested PCR). Restriction fragment length polymorphisms (RFLPs) were used to determine the heterogeneity of TTV. RESULTS: TTV and SEN-V were detected 96 (64%) and 84 (56%) of 150 HIV patients respectively. These rates were 34% (n=51) and 37.33% (n=56) in healthy blood donors (significant, p<0.05). PCR detected SEN-V/TTV DNA from 32 of the healthy blood donors (21.33%), while 65 (43.33%) of HIV patients were positive for SEN-V/TTV DNA. Of 150 HIV patients, 32.66% and 23.33% were positive for SEN-V-H and SEN-V-D, respectively and 18.66% (n=28) were co-infected with SEN-V-D/H. CONCLUSIONS: The prevalence of SEN-VD/H and TTV is higher in HIV patients than in healthy blood donors in Southern Iran. Our results suggest that TTV and SEN-V might play a role in the development of liver disease in patients with immunodeficiency diseases.
INTRODUCTION:Torque teno virus (TTV) and SEN virus are circular single-stranded DNA viruses that cause blood-borne infections. The SEN virus (SEN-V) was originally detected in the serum of an injection drug user infected with human immunodeficiency virus (HIV). Recently TTV was discovered as a potential causative agent of non-A-E hepatitis. The aim of this study was to investigate the prevalence of the SEN-V-D/H and TTV in HIVpatients and healthy blood donors in Iran. METHODS: One hundred and fifty HIVpatients with a mean age of 50.46 ± 18.46 years and 150 healthy blood donors with a mean age of 48.16 ± 13.73 years were included in this study. TTV and SEN-V were detected by the PCR and were quantitatively assayed by competitive PCR (nested and semi-nested PCR). Restriction fragment length polymorphisms (RFLPs) were used to determine the heterogeneity of TTV. RESULTS:TTV and SEN-V were detected 96 (64%) and 84 (56%) of 150 HIVpatients respectively. These rates were 34% (n=51) and 37.33% (n=56) in healthy blood donors (significant, p<0.05). PCR detected SEN-V/TTV DNA from 32 of the healthy blood donors (21.33%), while 65 (43.33%) of HIVpatients were positive for SEN-V/TTV DNA. Of 150 HIVpatients, 32.66% and 23.33% were positive for SEN-V-H and SEN-V-D, respectively and 18.66% (n=28) were co-infected with SEN-V-D/H. CONCLUSIONS: The prevalence of SEN-VD/H and TTV is higher in HIVpatients than in healthy blood donors in Southern Iran. Our results suggest that TTV and SEN-V might play a role in the development of liver disease in patients with immunodeficiency diseases.
Authors: Linlin Li; Xutao Deng; Antonio Charlys Da Costa; Roberta Bruhn; Steven G Deeks; Eric Delwart Journal: J Clin Virol Date: 2015-10-08 Impact factor: 3.168
Authors: Vasiliy I Reshetnyak; Igor V Maev; Alexandr I Burmistrov; Igor A Chekmazov; Tatiana I Karlovich Journal: World J Gastroenterol Date: 2020-04-21 Impact factor: 5.742
Authors: Elmoeiz A Elnagi; Thekra N Al-Maqati; Yaser Alnaam; Ahmed A Adam; Ali A Rabaan; Zeinab S Mohamed; Anisah Amer; Hussa L Almarfoi Journal: Saudi J Biol Sci Date: 2021-04-01 Impact factor: 4.219